Therapeutic checkpoint for acute myeloid leukemia requires further investigations. The authors here identify ST2+ Treg cells facilitate AML growth by inducing CD8+ T cell depletion and exhaustion, while targeting ST2 by antibodies depletes ST2+ Treg cells and improves AML prognosis.
- Hua Jiang
- Denggang Fu
- Sophie Paczesny
